European Commission Pharma Cartel Fine

137
SHARE

Transo-Pharm and Linnea, due to their proactive cooperation with the Commission’s investigation, secured a reduction in their fines. A 10% reduction was applied across the board to acknowledge the companies’ admission of guilt in participating in the cartel.

European Commission Pharma Cartel Fine : Deafening Silence

In a strange turn of events, Alkaloids of Australia, Alkaloids Corporation, Linnea, and Transo-Pharm chose not to comment on the matter when approached for their statements on Friday.

In an unprecedented move, the European Commission has unleashed its might on the pharmaceutical world, fining five giants for their role in a stomach-churning cartel.

Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea, and Transo-Pharm have been handed a colossal €13.4 million ($14.1 million) fine for conspiring to rig prices and quotas for a vital drug ingredient.

Their illicit actions exposed and condemned, while a whistleblower remains unscathed. C2 PHARMA, the heroic whistleblower, escaped the fine’s clutches by exposing the cartel that tainted the European Economic Area from 2005 to 2019.